*Some Market data delayed by 15 mins.

Lexicon Pharmaceuticals, Inc.

Symbol: LXRX (NASDAQ)
1.41 ▲ (4.07%) 0.055

Company Description:
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Key Stats
  • Today's Open: $1.35
  • Today's High: $1.415
  • Today's Low: $1.33
  • Today's Volume: 962.23K
  • Yesterday Close: $1.35
  • Yesterday High: $1.39
  • Yesterday Low: $1.28
  • Yesterday Volume: 2.60M
  • Last Min Volume: 1.08K
  • Last Min High: $1.405
  • Last Min Low: $1.405
  • Last Min VWAP: $1.405
Company Profile
  • Name: Lexicon Pharmaceuticals, Inc.
  • Website: https://www.lexpharma.com
  • Listed Date: 2000-04-07
  • Location: THE WOODLANDS, TX
  • Market Status: Active
  • CIK Number: 0001062822
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $490.59M
  • Round Lot: 100
  • Outstanding Shares: 363.40M
  • Asset Type: CS
RECENT FILINGS FOR LXRX
Filing Date Filing Type Format
2025-08-06 S-8 View
2025-08-06 10-Q View
2025-08-06 8-K View
2025-07-28 8-K View
2025-07-08 SCHEDULE 13G/A View
2025-07-03 8-K View
2025-06-09 3 View
2025-06-06 3 View
2025-06-03 4 View
2025-06-03 4 View
2025-06-03 4 View
2025-06-03 4 View
2025-06-03 4 View
2025-06-03 4 View
2025-06-03 4 View
2025-06-03 8-K View
2025-05-14 10-Q View
2025-05-13 4 View
2025-05-13 4 View
2025-05-13 4 View
Latest News on LXRX

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.